CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
- 1 April 2009
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 94 (4) , 596-598
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOPBlood, 2008
- Distribution Patterns of Dendritic Cells and T Cells in Diffuse Large B-Cell Lymphomas Correlate with PrognosesClinical Cancer Research, 2007
- Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expressionMolecular Immunology, 2006
- When the Lymphocyte Loses Its ClothesImmunity, 2003
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Genetic Control of MHC Class II ExpressionCell, 2002
- Class II Transactivator: Mastering the Art of Major Histocompatibility Complex ExpressionMolecular and Cellular Biology, 2000
- The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter elementNucleic Acids Research, 1998
- Characterization of the expressed CIITA allele in the class II MHC transcriptional mutant RJ2.2.5Immunogenetics, 1995